Solarvest BioEnergy Inc. announced that Mr. Michael Farley has been appointed as President of the Company effective immediately following the resignation of Mr. Claes Ellegaard who has agreed to tender his resignation. Mr. Farley is an entrepreneur and corporate, business advisor to health and wellness companies in international markets. Dr. Farley was involved in dozens of financial, market entry and M&A transactions since the early 2000s.

He is also partnered with a corporate advisory firm in Switzerland offering IR services to NA life science small caps in Europe. In the 1990s, Mr. Farley managed technology and investment programs at the Canadian Foreign Affairs Department. He holds a PhD in the Philosophy of Science from the Université de Montréal.

Solarvest announced that Mr. Garth Greenham has been appointed as COO of the Company effective October 31, 2023. Mr. Greenham is an executive of the Company and a corporate director with an extensive record with both privately-held and publicly-traded health care companies. He served as President of the global aquaculture division of Novartis Inc. He started his career with Johnson & Johnson (J&J) where he served 15 years mostly with McNeil Pharmaceutical in numerous management positions in Operations and Contract & Export Sales.

He joined Cobequid Life Sciences Inc.(KQR) and served as Director of Sales, Marketing & Operations for nine years and helped grow the company to global leader in the field of aquaculture animal vaccines.